LiverRight, the nation's only National Virtual Clinic for diagnosing and treating Liver Disease in Adults, announces that its telemedicine appointments in 2026 will offer metrics collection using what ...

U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat ...

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient dosed in ...

The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Yellowing skin or eyes suggests jaundice from bilirubin buildup; urgent evaluation needed to rule out liver disease.

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

These suits represent the next frontier: whether manufacturers of regulated cannabis products may be held liable for injuries ...

PREMATURE birth is a significant public health challenge, not only in Tanzania but also across the globe. It poses major ...

Kerala has reported its highest-ever number of Hepatitis A cases. As of December 30, 2025, the state recorded 31,536 ...